Wall Street PR

Investor Takeaway: Healthcare Trust Of America Inc (NYSE:HTA), China XD Plastics Co Ltd (NASDAQ:CXDC), Calumet Specialty Products Partners, L.P (NASDAQ:CLMT)

Boston, MA 05/19/2014 (wallstreetpr) – Healthcare Trust Of America Inc (NYSE:HTA), an REIT that had its investment rating upgraded to BBB at S&P, said it looks to a positive future with the launch of Revista, a data services program. The data service for the medical real estate officially launches later this month. Its first rollout will be in Northeastern U.S. and later the entire country. The data service will provide investors with greater insight into the medical real estate activities for the purposes of supporting informed investment decisions. HTA is a founding partner for the launch of the service. The company expects the program to expand trading activities in the medical real estate space. REITs are poised to benefit from the strong demand for office, retail and residential spaces in the face of growing jobs and widespread site of expansion by companies. Shares of Healthcare Trust Of America Inc (NYSE:HTA) are up 25.2 percent year-to-date.

China XD Plastics Co Ltd (NASDAQ:CXDC) having reported improvement in profit and revenue in 1Q2014, intends to up spending on research and development. The company noted that its higher-end products category experienced strong sales and enjoyed higher margins. It believes that increased investment in products development will result into creation of even more premium products that can support higher margin and revenue for the company. But even in a robust research and development mode, the company expects to focus on market needs so that it only brings to the market the products with a wide appeal. The company reported 1Q revenue of $223.6 million and profit of $22 million. It expects to generate between $950 and $1.05 billion in revenue and profit between $100 and $120 million in 2014. The improving investor confidence in the company is best captured by the 61.6 percent increase in stock price since the beginning of 2014.

Although analysts at TheStreet recently issued a bearish view on the stock of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT), investors look unperturbed. Shares of the company continue to trend upward, and last five days saw the stock up 5.7 percent. TheStreet lowered the stock to a “hold,” down from a “buy” rating that the firm previously issued on the stock. The analysts were worried about the company’s weakening net income and poor debt position.

Published by Lisa Ray

Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.